Hadziyannis SJ - Search Results

1

Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.

Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. Manesis EK, et al. Among authors: hadziyannis sj. Am J Gastroenterol. 2003 Oct;98(10):2261-7. doi: 10.1111/j.1572-0241.2003.07715.x. Am J Gastroenterol. 2003. PMID: 14572577

2

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease.

Papatheodoridis GV, Dimou E, Laras A, Papadimitropoulos V, Hadziyannis SJ. Papatheodoridis GV, et al. Among authors: hadziyannis sj. Hepatology. 2002 Jul;36(1):219-26. doi: 10.1053/jhep.2002.33894. Hepatology. 2002. PMID: 12085368

3

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial.

Papatheodoridis GV, Hadziyannis ES, Deutsch M, Hadziyannis SJ. Papatheodoridis GV, et al. Among authors: hadziyannis sj, hadziyannis es. Am J Gastroenterol. 2002 Aug;97(8):2063-70. doi: 10.1111/j.1572-0241.2002.05923.x. Am J Gastroenterol. 2002. PMID: 12190178 Clinical Trial.

4

Treatment of HBeAg-negative chronic hepatitis B.

Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D. Hadziyannis SJ, et al. Semin Liver Dis. 2003 Feb;23(1):81-8. doi: 10.1055/s-2003-37584. Semin Liver Dis. 2003. PMID: 12616453 Review.

5

Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.

Papatheodoridis GV, Dimou E, Dimakopoulos K, Manolakopoulos S, Rapti I, Kitis G, Tzourmakliotis D, Manesis E, Hadziyannis SJ. Papatheodoridis GV, et al. Among authors: hadziyannis sj. Hepatology. 2005 Jul;42(1):121-9. doi: 10.1002/hep.20760. Hepatology. 2005. PMID: 15962291

6

Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment.

Hadziyannis SJ, Papatheodoridis GV. Hadziyannis SJ, et al. Semin Liver Dis. 2006 May;26(2):130-41. doi: 10.1055/s-2006-939751. Semin Liver Dis. 2006. PMID: 16673291 Review.

7

Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels.

Manesis EK, Hadziyannis ES, Angelopoulou OP, Hadziyannis SJ. Manesis EK, et al. Among authors: hadziyannis sj, hadziyannis es. Antivir Ther. 2007;12(1):73-82. Antivir Ther. 2007. PMID: 17503750

8

Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.

Cholongitas E, Papatheodoridis GV, Manesis EK, Petraki K, Tiniakos D, Hadziyannis SJ. Cholongitas E, et al. Among authors: hadziyannis sj. J Med Virol. 2011 Jul;83(7):1165-71. doi: 10.1002/jmv.21780. J Med Virol. 2011. PMID: 21567420

9

Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B.

Laras A, Papatheodoridi M, Panopoulou E, Papatheodoridis GV, Hadziyannis SJ, Hadziyannis E. Laras A, et al. Among authors: hadziyannis sj. Virol J. 2022 Jan 29;19(1):22. doi: 10.1186/s12985-022-01749-7. Virol J. 2022. PMID: 35093105 Free PMC article.

10

Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study.

Hadziyannis SJ, Manesis EK, Papakonstantinou A. Hadziyannis SJ, et al. J Hepatol. 1999 Aug;31(2):210-4. doi: 10.1016/s0168-8278(99)80215-3. J Hepatol. 1999. PMID: 10453931 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters